Home›Research›Compare›AICAR vs Liraglutide
Peptide ComparisonAICAR vs Liraglutide
Both are Metabolic peptides.
Liraglutide
Victoza
Half-life: 13 hours
51 providers listed
Liraglutide is FDA-approved, while AICAR is investigational — the clearest structural difference between them.
AICAR
Evidence
Half-life
—
Liraglutide
Evidence
Half-life
13 hours
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Liraglutide |
| Further along in FDA review | Liraglutide |
| More provider options (3 vs 51) | Liraglutide |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
AICAR
Liraglutide
AICAR
Targeting AMPK Networks for Male Reproductive Health: Mechanisms and Emerging Therapies.
Thapsigargin-induced autophagic flux impairment and inflammation are potentiated by CLN3 deficiency and allev…
The AMPK-PGC-1α-SIRT3 axis mediates mitochondrial metabolic dysfunction and neuronal senescence induced by Al…
Berberine Regulates Hepatic Fatty Acid Metabolism via AMPK/SIRT1/PGC-1α Pathway.
+8 more
Liraglutide
Semaglutide vs liraglutide for weight loss in adults with overweight or obesity
A randomized, controlled trial of 3.0 mg of liraglutide in weight management
Comparative Effects of Individual Glucagon-Like Peptide-1 Receptor Agonist-Based Medications on Direct Measur…
GLP-1 receptor agonists in pediatric obesity and diabetes: a systematic review of efficacy, metabolic effects…
+11 more
About AICAR
Converted intracellularly to ZMP, a potent AMPK activator. AMPK activation increases fatty acid oxidation, glucose uptake, and mitochondrial biogenesis — the same metabolic pathways activated by sustained aerobic exercise.
About Liraglutide
GLP-1 receptor agonist; slows gastric emptying, increases satiety, reduces glucagon secretion
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
AICAR
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Liraglutide
Risk of thyroid C-cell tumors (dose- and duration-dependent in rodents; human relevance undetermined).
Source: FDA label
Under clinical review
Being verified by our medical team before we display monitoring guidance for this peptide.
AICAR
Liraglutide
Not enough vendor pricing yet.
Where to source these peptides
AICAR
3 listed
Browse directory →
Providers offeringLiraglutide
51 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Metabolic Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 27, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). AICAR vs Liraglutide — Per-mg Price Comparison. Retrieved July 29, 2026, from https://peptidebase.io/peptides/compare/aicar/liraglutide